Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | URGN | DMRA | ||
| Company | Akcea Therapeutics Inc | Urogen Pharma Ltd | Damora Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.15 | 37.54 | 27.09 | ||
| High | 18.17 | 38.58 | 30.18 | ||
| Low | 18.13 | 36.88 | 26.29 | ||
| Latest | 18.17 | 38.02 | 29.98 | ||
| Change | +0.03 | +0.08 | +2.89 | ||
| % Change | +0.17% | +0.21% | +10.67% | ||
| Volume | 815,300 | 821,800 | 761,100 | ||
| 20-Day Average Volume | 661,490 | 685,970 | 928,065 | ||
| Previous Close | 18.14 | 37.94 | 27.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 32.48 | 22.74 | ||
| 20-Day Raw Stochastic | 70.59% | 88.14% | 98.23% | ||
| 20-Day Relative Strength | 73.10 | 74.49 | 65.68 | ||
| Weighted Alpha | -23.90 | +168.30 | -10.39 | ||
| Today's Opinion | 72% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 8% Buy | 88% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +10.59% since 06/25/26 | +32.83% since 06/25/26 | ||
| Low | 18.08 on 10/05/20 | 33.73 on 06/26/26 | 22.05 on 06/26/26 | ||
| High | 18.17 on 10/09/20 | 39.58 on 07/01/26 | 30.18 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +43.26% since 06/02/26 | +30.63% since 06/02/26 | ||
| Low | 18.05 on 09/21/20 | 26.23 on 06/03/26 | 18.59 on 06/10/26 | ||
| High | 18.22 on 09/28/20 | 39.58 on 07/01/26 | 30.18 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | +102.02% since 04/02/26 | +19.49% since 04/02/26 | ||
| Low | 9.81 on 08/05/20 | 17.75 on 04/07/26 | 18.59 on 06/10/26 | ||
| High | 19.65 on 08/31/20 | 39.58 on 07/01/26 | 30.18 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | +67.42% since 01/02/26 | +37.40% since 01/02/26 | ||
| Low | 9.81 on 08/05/20 | 16.50 on 03/30/26 | 16.50 on 03/20/26 | ||
| High | 19.65 on 08/31/20 | 39.58 on 07/01/26 | 33.99 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 1,852,411 | 1,845,359 | ||
| Shares Outstanding, K | 101,599 | 48,722 | 61,553 | ||
| Annual Sales | 488,540,000 | 109,790,000 | 0 | ||
| Annual Net Income | 40,770,000 | -153,490,000 | -209,840,000 | ||
| Last Quarter Sales | 22,380,000 | 50,960,000 | 0 | ||
| Last Quarter Net Income | -49,580,000 | -23,570,000 | -27,780,000 | ||
| 60-Month Beta | 1.45 | 1.56 | 1.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -0.47 on 05/06/26 | -0.62 on 05/12/26 | ||
| Earnings Date | 11/03/20 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||